Abstract
The Characteristics of Cardiovascular Adverse Events in Therapy with Immune Checkpoint Inhibitors: The Result of Work of the Multi-Disciplinary Team
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have